A detailed history of Lineweaver Wealth Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Lineweaver Wealth Advisors, LLC holds 12,374 shares of ABBV stock, worth $2.48 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares
12,374
Previous 12,086 2.38%
Holding current value
$2.48 Million
Previous $2.07 Million 17.91%
% of portfolio
0.49%
Previous 0.45%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$163.84 - $199.33 $47,185 - $57,407
288 Added 2.38%
12,374 $2.44 Million
Q2 2024

Aug 01, 2024

BUY
$154.79 - $180.76 $1.56 Million - $1.82 Million
10,065 Added 498.02%
12,086 $2.07 Million
Q1 2024

Apr 30, 2024

BUY
$159.82 - $182.1 $1,758 - $2,003
11 Added 0.55%
2,021 $368,000
Q4 2023

Jan 19, 2024

SELL
$137.6 - $154.97 $65,222 - $73,455
-474 Reduced 19.08%
2,010 $311,000
Q3 2023

Oct 19, 2023

BUY
$133.59 - $154.65 $4,408 - $5,103
33 Added 1.35%
2,484 $370,000
Q2 2023

Jul 26, 2023

BUY
$132.51 - $164.9 $14,973 - $18,633
113 Added 4.83%
2,451 $330,000
Q1 2023

May 02, 2023

BUY
$144.61 - $166.54 $15,328 - $17,653
106 Added 4.75%
2,338 $372,000
Q4 2022

Jan 26, 2023

BUY
$138.31 - $165.87 $2,489 - $2,985
18 Added 0.81%
2,232 $0
Q3 2022

Nov 01, 2022

BUY
$134.21 - $153.93 $24,560 - $28,169
183 Added 9.01%
2,214 $297,000
Q2 2022

Jul 26, 2022

BUY
$137.62 - $174.96 $78,168 - $99,377
568 Added 38.82%
2,031 $311,000
Q1 2022

May 09, 2022

BUY
$131.98 - $163.75 $193,086 - $239,566
1,463 New
1,463 $237,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $355B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Lineweaver Wealth Advisors, LLC Portfolio

Follow Lineweaver Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lineweaver Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lineweaver Wealth Advisors, LLC with notifications on news.